Oncogene Contents: Volume 41 Number 27

In this Issue: Article Correction

Oncogene Contents: Volume 41 Issue 27

Article

Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment Yoshihiro Morimoto, Atsushi Fushimi, Nami Yamashita, Masayuki Hagiwara, Atrayee Bhattacharya et al. Article | 10 June 2022 Oncogene 41 | doi:10.1038/s41388-022-02361-3

RB loss determines selective resistance and novel vulnerabilities in ER-positive breast cancer models Vishnu Kumarasamy, Ram Nambiar, Jianxin Wang, Hanna Rosenheck, Agnieszka K. Witkiewicz et al. Article | 09 June 2022 Oncogene 41 | doi:10.1038/s41388-022-02362-2

Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma Yongyun Li, Jie Yang, Qianqian Zhang, Shiqiong Xu, Wei Sun et al. Article | 13 June 2022 Oncogene 41 | doi:10.1038/s41388-022-02364-0

Identification of a novel Calpain-2-SRC feed-back loop as necessity for β-Catenin accumulation and signaling activation in hepatocellular carcinoma Xiao-Lu Ma, Ke-Yu Zhu, Yue-Da Chen, Wei-Guo Tang, Su-Hong Xie et al. Article | 13 June 2022 Oncogene 41 | doi:10.1038/s41388-022-02367-x

PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma Yating Liu, Lianlian Ouyang, Chao Mao, Yuanbing Chen, Tiansheng Li et al. Article | 10 June 2022 Oncogene 41 | doi:10.1038/s41388-022-02370-2

Correction

Correction to: An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment Takeshi Motohara, Kenta Masuda, Matteo Morotti, Yiyan Zheng, Salma El-Sahhar et al. Correction | 06 June 2022 Oncogene 41 | doi:10.1038/s41388-022-02356-0

Correction: SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signaling Zhuoxian Rong, Lu Zhang, Zhi Li, Zhi Xiao, Yumei Duan et al. Correction | 14 June 2022 Oncogene 41 | doi:10.1038/s41388-022-02374-y

Journal Info Submit Manuscript RSS Feed

This email has been sent to ignoble.experiment@arconati.us by Oncogene.

Unsubscribe Manage Alerts Privacy policy Contact us

Springer Nature Limited is a company registered in England and Wales under Company Number 785998 with its registered office at The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom

Nature is part of Springer Nature. © 2022 Springer Nature Limited. All rights reserved.